InsiderClue
← All stocks

Kura Oncology, Inc.

KURA Net buying
CIK 0001422143 #2514 in the set updated 17 Sep 2026
Bought (1 mo)
$2.35M
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$449.34K
$449.34K on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 2 sales
Net
+$1.90M
+$2.35M against sales at will

By person

9 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
WILSON TROY EDWARD
President and CEO
$2.35M (2)
—
+$2.35M
914,650
1.03%
$11.33M
+226.5%
Bair Teresa Brophy
Chief Legal Officer
—
$397.68K (1) scheduled
−$397.68K
195,444
0.2197%
$2.42M
+168.5%
Powl Brian T.
Chief Commercial Officer
—
$51.66K (1) scheduled
−$51.66K
169,269
0.1903%
$2.10M
+979.7%
Leoni Mollie
Chief Medical Officer
—
—
—
182,345
0.2050%
$2.26M
+288.2%
FORD KATHLEEN
Chief Operating Officer
—
—
—
153,560
0.1726%
$1.90M
+22.5%
DOYLE THOMAS JAMES
SVP, Finance & Accounting
—
—
—
145,167
0.1632%
$1.80M
+175.7%
Burrows Francis
Chief Scientific Officer
—
—
—
32,424
0.0364%
$401.73K
+31.7%
Hasnain Faheem
Director
—
—
—
23,983
0.0270%
$297.15K
0.0%
Malley Thomas
Director
—
—
—
10,000
0.0112%
$123.90K
—

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
WILSON TROY EDWARD
24 Aug 2026
President and CEO
Buy indirect
100,000
$12.39
$1.24M
WILSON TROY EDWARD
17 Aug 2026
President and CEO
Buy indirect
100,000
$11.12
$1.11M
Show all 4 transactions →

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 3 Jan 2017